On February 7th, Ding Ye, member of the National Pharmacopoeia Commission and director of the Institute of Traditional Chinese Medicine at the Hunan Provincial Institute for Drug Control and Testing, led a delegation to visit and conduct research at our company. Accompanying them were Shen Fanshun, Chairman of the company, Tang Zhengping, Executive Deputy General Manager, and Yuan Huaijian, traceability consultant.

The research team visited the company's exhibition hall, quality inspection center, pharmaceutical research institute, and intelligent production line for traditional Chinese medicine extraction.

The research team fully affirmed the company's development achieved in recent years, as well as its investment in product quality control, production intelligence, and product research and development. They also engaged in discussions with relevant technical leaders of the company regarding the progress of the Xiangjiuwei project, as well as technical exchanges on the research of Hunan Chinese herbal medicine quality standards and the improvement of the company's proprietary medicine preparation quality standards.

Director Ding Ye proposed that during the research process of Chinese herbal medicine quality standards, the company should pay attention to the key points and technical aspects, and should conduct business consultations and exchanges with the provincial bureau and provincial academy, jointly contributing to the compilation of the new version of Hunan Province's Chinese herbal medicine standards.